Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1998-11-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0269-9370
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1395
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9708423-Anti-HIV Agents,
pubmed-meshheading:9708423-HIV Infections,
pubmed-meshheading:9708423-HIV Protease Inhibitors,
pubmed-meshheading:9708423-Humans,
pubmed-meshheading:9708423-Indinavir,
pubmed-meshheading:9708423-Kidney Failure, Chronic,
pubmed-meshheading:9708423-Male,
pubmed-meshheading:9708423-Renal Dialysis
|
pubmed:year |
1998
|
pubmed:articleTitle |
Indinavir pharmacokinetics in haemodialysis-dependent end-stage renal failure.
|
pubmed:publicationType |
Letter,
Case Reports
|